Past Visits Present: TCF/LEFs Partner with ATFs for β-Catenin–Independent Activity

article has not abstract

Vyšlo v časopise: Past Visits Present: TCF/LEFs Partner with ATFs for β-Catenin–Independent Activity. PLoS Genet 9(8): e32767. doi:10.1371/journal.pgen.1003745
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003745

Souhrn

article has not abstract

Zdroje

1. BehrensJ, von KriesJP, KuhlM, BruhnL, WedlichD, et al. (1996) Functional interaction of b-catenin with the transcription factor LEF-1. Nature 382: 638–642.

2. HuberO, KornR, McLaughlinJ, OhsugiM, HerrmannB, et al. (1996) Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59: 3–10.

3. MolenaarM, van de WeteringM, OosterwegelM, Peterson-MaduroJ, GodsaveS, et al. (1996) XTCF-3 transcription factor mediates b-catenin-induced axis formation in Xenopus embryos. Cell 86: 391–399.

4. WatermanML, FischerWH, JonesKA (1991) A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev 5: 656–669.

5. TravisA, AmsterdamA, BelangerC, GrosschedlR (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function. Genes Dev 5: 880–894.

6. van de WeteringM, OosterwegelM, DooijesD, CleversH (1991) Identification and cloning of TCF-1, a T lymphocyte specific transcription factor containing a sequence-specific HMG box. EMBO J 10: 123–132.

7. OosterwegelM, van de WeteringM, HolstegeFC, ProsserHM, OwenMJ, et al. (1991) TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers. Int Immuno 3: 1189–1192.

8. van de WeteringM, CastropJ, KorinekV, CleversH (1996) Extensive alternative splicing and dual promoter usage generate Tcf-protein isoforms with differential transcription control properties. Mol Cell Biol 16: 745–752.

9. CarlssonP, WatermanM, JonesK (1993) The hLEF/TCF-1a HMG protein contains a context-dependent transcriptional activation domain that induces the TCRa enhancer in T cells. Genes Dev 7: 2418–2430.

10. HovanesK, LiTW, MunguiaJE, TruongT, MilovanovicT, et al. (2001) Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28: 53–57.

11. HovanesK, LiTWH, WatermanML (2000) The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28: 1994–2003.

12. GieseK, GrosschedlR (1993) LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J 12: 4667–4676.

13. GrumolatoL, LiuG, HaremakiT, MungamuriSK, MongP, et al. (2013) β-catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors. PLoS Genet 9: e1003603 doi:10.1371/journal.pgen.1003603

14. Lopez-BergamiP, LauE, RonaiZ (2010) Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 10: 65–76.

15. LeidenJM (1992) Transcriptional regulation during T-cell development: the alpha TCR gene as a molecular model. Immunol Today 13: 22–30.

16. GieseK, KingsleyC, KirshnerJR, GrosschedlR (1995) Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9: 995–1008.

17. LiuF, van den BroekO, DestreeO, HopplerS (2005) Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/{beta}-catenin signalling in mesoderm development. Development 132: 5375–5385.

18. LentoW, CongdonK, VoermansC, KritzikM, ReyaT (2013) Wnt signaling in normal and malignant hematopoiesis. Cold Spring Harb Perspect Biol 5.

19. RoozenPP, BrugmanMH, StaalFJ (2012) Differential requirements for Wnt and Notch signaling in hematopoietic versus thymic niches. Ann N Y Acad Sci 1266: 78–93.

20. TakedaH, LyleS, LazarAJ, ZouboulisCC, SmythI, et al. (2006) Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 12: 395–397.

21. NiemannC, OwensDM, HulskenJ, BirchmeierW, WattFM (2002) Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development 129: 95–109.

22. HatzisP, van der FlierLG, van DrielMA, GuryevV, NielsenF, et al. (2008) Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 28: 2732–2744.

23. MokryM, HatzisP, de BruijnE, KosterJ, VersteegR, et al. (2010) Efficient double fragmentation ChIP-seq provides nucleotide resolution protein-DNA binding profiles. PLoS ONE 5: e15092 doi:10.1371/journal.pone.0015092

24. BlahnikKR, DouL, O'GeenH, McPhillipsT, XuX, et al. (2010) Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Res 38: e13.

25. FrietzeS, WangR, YaoL, TakYG, YeZ, et al. (2012) Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3. Genome Biol 13: R52.

26. BottomlyD, KylerSL, McWeeneySK, YochumGS (2010) Identification of b-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 38: 5735–5745.